Tomohiro Okagawa

A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma

Naoya Maekawa, Satoru Konnai, Satoshi Takagi et al. · Scientific Reports · 2017 · 162 citations · Full text

Life Sciences, Immunology, Oncology +17

Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma

Naoya Maekawa, Satoru Konnai, Tomohiro Okagawa et al. · PLoS ONE · 2016 · 134 citations · Full text

Medicine, Immunology, Oncology +17

PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma

Naoya Maekawa, Satoru Konnai, Maki Nishimura et al. · npj Precision Oncology · 2021 · 120 citations · Full text

Medicine, Oncology, Veterinary Clinical Sciences +16

Expression of PD-L1 on Canine Tumor Cells and Enhancement of IFN-γ Production from Tumor-Infiltrating Cells by PD-L1 Blockade

Naoya Maekawa, Satoru Konnai, Ryoyo Ikebuchi et al. · PLoS ONE · 2014 · 115 citations · Full text

Life Sciences, Immunology, Oncology +17

Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro

Ryoyo Ikebuchi, Satoru Konnai, Tomohiro Okagawa et al. · Veterinary Research · 2013 · 66 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12